Verge Genomics Wants To Cure Neurodegenerative Diseases Through Advanced Algorithms
Launching out of Y Combinator, Verge Genomics is looking to find cures for brain diseases. Alzheimers, ALS, and Parkinsons are complex diseases that usually involve a network of genes, as opposed to a single gene.
According to the company, over 99.9 percent of drug discoveries ultimately fail because researchers are looking at a single gene at a time. But Verge Genomics is able to cure brain diseases 1000x more quickly than big pharma by using algorithms to map out the human genome and understand hundreds of genes at once.